Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Invested Capital (2019 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Return on Invested Capital for 7 consecutive years, with 1.46% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital fell 96.0% year-over-year to 1.46%, compared with a TTM value of 1.46% through Sep 2025, down 96.0%, and an annual FY2024 reading of 0.34%, up 29.0% over the prior year.
  • Return on Invested Capital was 1.46% for Q3 2025 at Tandem Diabetes Care, down from 1.23% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.08% in Q3 2021 and bottomed at 1.46% in Q3 2025.
  • Average Return on Invested Capital over 5 years is 0.43%, with a median of 0.5% recorded in 2024.
  • The sharpest move saw Return on Invested Capital skyrocketed 39bps in 2024, then plummeted -96bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.05% in 2021, then tumbled by -508bps to 0.22% in 2022, then plummeted by -242bps to 0.75% in 2023, then surged by 53bps to 0.36% in 2024, then crashed by -311bps to 1.46% in 2025.
  • Business Quant data shows Return on Invested Capital for TNDM at 1.46% in Q3 2025, 1.23% in Q2 2025, and 0.75% in Q1 2025.